Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPD crossover study of tiotropium and salbutamol with ventilation-perfusion imaging
ACTRN12607000482460Phase 4Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tiotropium and salbutamol in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Woolcock Institute of Medical Research. Primary endpoint: Ventilation perfusion before and after treatment. Started Aug 2007; status: completed.
02
Drugs
tiotropiumsalbutamol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12607000482460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000482460.